How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
I am an occupational therapist and a PhD student in health sciences. I am interested in the social participation of people living with a neuromuscular disease, and more specifically the functional impact of cognitive impairments in people living with myotonic dystrophy type 1. My research aims to support the practice of health professionals to improve care and services in this regard.
Background. Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a progressive disorder where upper and lower extremities motor performances may bring participation restriction. Purpose. To document participation in adults with ARSAC and explore associations with motor performances. Method. Twenty-eight participants took part in th...
Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy among adults. This cross-sectional study documents the level of independence in the instrumental activities of daily living (IADL) and explores the impact of executive functions and apathy on IADL accomplishment level among adults with the childhood phenotype of DM1. IADL accompl...
Background The childhood phenotype of myotonic dystrophy type 1 (DM1) involves impaired cognitive functioning starting in infancy, which may compromise later on their ability to carry out instrumental activities of daily living (IADLs) necessary for living independently. The current study aims to document the ability to perform IADLs among adults w...
I aim to develop knowledge translation strategies in rare diseases for health care providers, patients, and their families to improve clinical care. With the Neuromuscular Disease Network for Canada (NMD4C), I supports the Knowledge Translation team through developing knowledge and skills, defining barriers, and reducing the knowledge-to-action gap by developing various tools including clinical practice guidelines in the neuromuscular disease field.
(1) Propose approaches to address the subject of sexuality with people who have a neuromuscular disease; (2) Provide healthcare professionals with tools by identifying and documenting a set of interventions that can be applied in their practice.